A Survey of the FDA’s Adverse Event Reporting System Database Concerning Urogenital Tract Infections and Sodium Glucose Cotransporter‐2 Inhibitor Use

INTRODUCTION: We tested the possible association between sodium glucose cotransporter-2 inhibitor (SGLT-2i) use and urogenital tract infection (UTI) occurrences by assessing the publicly available US Food and Drug Administration Adverse Event Reporting System (FAERS). METHODS: Disproportionality ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Juan, Yang, Jincheng, Zhao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531563/
https://www.ncbi.nlm.nih.gov/pubmed/30953300
http://dx.doi.org/10.1007/s13300-019-0611-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531563/
https://www.ncbi.nlm.nih.gov/pubmed/30953300
http://dx.doi.org/10.1007/s13300-019-0611-9

Ejemplares similares